Clinical trial
Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy
NCT03000309 is registered in ClinicalTrials.gov with Derm Research, PLLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy
- Lead sponsor
- Derm Research, PLLC
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 29, 2016
- Completion date
- April 25, 2018
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
plaque psoriasis